Function of carnitine in metabolism of pregnant women and of fetuses in the prenatal and perinatal period - Animal and clinical studies;TIEREXPERIMENTELLE UND KLINISCHE UNTERSUCHUNGEN UBER DIE BEDEUTUNG DES CARNITINS FUR DEN STOFFWECHSEL DER SCHWANGEREN UND DES FETEN WAHREND DER PRA- UND PERINATALPERIODE

Wiener Klinische Wochenschrift

Volumn 108, Issue 2, 1996, Pages 33-39

  Lohninger, A ^a   Laschan, C ^a   Auer, B ^a   Linhart, L ^a   Salzer, H ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

betamethasone; L carnitine; pregnancy; RDS; surfactant

Indexed keywords

BETAMETHASONE; CARNITINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; SURFACTANT;

ANIMAL EXPERIMENT; CARNITINE DEFICIENCY; FEMALE; FETUS; HUMAN; METABOLISM; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; RESPIRATORY DISTRESS SYNDROME; REVIEW; ANIMAL; ENERGY METABOLISM; FETOMATERNAL TRANSFUSION; FETUS MATURITY; LUNG; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; RAT;

ANIMALS; CARNITINE; ENERGY METABOLISM; FEMALE; FETAL ORGAN MATURITY; HUMANS; INFANT, NEWBORN; LUNG; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; RATS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0030033974     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Andrew G, Chan G, Shiff D (1976) Lipid metabolism in the neonate. I. The effect of intralipid infusion on plasma triglyceride and free fatty acid concentrations in the neonate. J Pediat 88: 273-278
2. Bargen-Lockner C, Hahn P, Wittmann B (1981) Plasma carnitine in pregnancy. Am J Obstet Gynecol 140: 412
3. Batenburg JJ (1992) Surfactant phospholipids: synthesis and storage. Am J Physiol 262: L367-L385
4. Beier G, Tolpeit E, Frischenschlager S, Helnwein F, Steinkellner G (1995) Bundesministerium für Gesundheit, Sport und Konsumentenschutz
5. Bieber LL (1988) Carnitine. Ann Rev Biochem 57: 261-283
6. Bohmer T, Rydning A, Soberg HE (1974) Carnitine levels in human serum in health and disease. Clin Chim Acta 57: 55-61
7. Boyd EM (1934) Blood lipids in the puerperium. Am J Obstet Gynecol 29: 797-805
8. Brass EP, Hiatt WR (1994) Carnitine metabolism during exercise. Life Sci 54: 1383-1393
9. Bremer J (1983) Carnitine-metabolism and functions. Physiol Rev 63: 1420-1480
10. Cederblad G, Fahraeus L, Lindgren K (1986) Plasma carnitine and renal-carnitine clearance during pregnancy. Am J Clin Nutr 44: 379-383
11. Cederblad G, Niklasson A, Rydgren B, Alberktsson-Wikland A, Olegard R (1985) Carnitine in matenal and neonatal plasma. Acta Pediatr Scand 74: 500
12. Coleman RA (1986) Placental metabolism and transport lipid. Federation Proc 45: 2519-2523
13. Crowley P, Chalmers I, Keirse M (1990) The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 97: 11-25
14. Duran M, Loof NE. Ketting D, Dorland L (1990) Secondary carnitine deficiency. J Clin Chem Clin Biochem 28: 359-363
15. Duran M, Mitchell G, de Klerk JBC, de Jager JP, Hofkamp M, Bruinvis L, Ketting D, Saudubray JM, Wadman SK (1985) Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr 107: 397-404
16. Frohlich J, Hahn P, Cleator I (1980) Changes in plasma carnitine levels after jejunal bypass. Lancet: 1085
17. Hahn P (1982) Development of lipid metabolism. Annu Rev Nutr 2: 91-111
18. Hoppel CL, Davis AT (1986) Inter-tissue relationship in the synthesis and distribution of carnitine. Biochem Soc Trans 14: 673-674
19. Gibson KM, Breuer J, Nyhan WL (1988) 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients. Eur J Pediatr 148: 180-186
20. Kurz C, Arbeiter K, Obermair A, Salzer H, Salzer HR, Lohninger A (1993) L-Carnitin-Bethamethason Kombinationstherapie versus alleiniger Betamethasontherapie als Prophylaxe des Atemnotsyndroms. Z Geburtshilfe Perinatol 197:215-220
21. Kidouchi K, Niwa T, Nohara D, Asai K, Sugiyama N, Morishita H, Kobayashi M, Wada Y (1988) Urinary acylcarnitines in a patient with neonatal multiple acyl-CoA dehydrogenation deficiency, quantified by a carboxylic acid analyzer with a reversed-phase column. Clin Chim Acta 173: 263-272
22. Lombard KA, Olson AL, Nelson SE, Rebouche CJ (1989) Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am J Clin Nutr 50: 857-867
23. Lohninger A, Preis P, Linhard L, Sommogy SV, Landau M, Kaiser E (1990) Determination of plasma free fatty acids, free cholesterol, cholesteryl esters, and triacylglycerols directly from total extract by capillary gas chromatography. Anal Biochem 186: 243-250
24. Lohninger A, Krieglsteiner HP, Nikiforov A, Erhardt W, Specker M, Martin G, Kaiser E (1984) Comparison of the effects of betamethasone and L-carnitine on dipalmitoyl phosphatidylcholine content and phosphatidylcholine species composition in fetal rat lungs. Pediatr Res 18: 1246-1252
25. Lohninger A, Krieglsteiner HP, Salzer H, Erhardt W, Eppl W, Kaiser E (1986) Studies of the effect of L-thyroxine, L-carnitine and an L-thyroxine-L-carnitine combination on dipalmitoyl phosphatidylcholine content and on phosphatidylcholine species composition in fetal rat lung. Pediatr Res 20: 1280-1283
26. Lohninger A, Krieglsteiner HP, Salzer H, Riedl W, Erhardt W, Kaiser E (1986) Studies on the effects of betamethasone, L-carnitine, and betamethasone-L-carnitine combinations on the dipalmitoyl phosphatidylcholine content and phosphatidylcholine species composition in fetal rat lungs. J Clin Chem Clin Biochem 24: 361-368
27. Lohninger A, Krieglsteiner HP, Salzer H, Erhardt W, Kaiser E (1985) Role of L-carnitine in perinatal metabolism and effects of L-carnitine administration on dipalmitoyl phosphatidylcholine content in fetal rat lungs and human amniotic fluid. In: Lohninger A, Kaiser E (eds) Carnitineits role in lung and heart disorders. Karger, Basel München Paris London, pp 66-99
28. Lohninger A, Böck P, Dadak C, Feiks A, Kaiser E (1990) Effect of carnitine on fetal rat lung dipalmitoyl phosphatidylcholine content and lung morphology. J Clin Chem Clin Biochem 28: 313-318
29. Lohninger A, Krieglsteiner HP, Stangl H. Effects of prenatal treatment with betamethasone and L-carnitine on the fetal and maternal rat lung. Eur J Clin Chem Clin Biochem (submitted)
30. Lohninger AK, Bock P, Salzer H, Sevelda P, Lohninger AF (1994) Antenatal betamethasone-dose-effects on fetal rat lung morphology and surfactant. J Perinat Med 22: 319-328
31. Lohninger A, Salzer H, Auer B, Lechner S (1996) Prenatal effects of betamethasone-L-carnitine combinatinos on fetal rat lung. J Perinat Med (in press)
32. Mallampalli RK, Salome RG, Hunninghake GW (1993) Lung CTP: choline phosphate cytidyllytransferase: activation of cytosolic species by unsaturated fatty acid. Am J Physiol 265: L153-L163
33. Montgomery JA, Mamer OA (1989) Measurement of urinary and acylcarnitines: quantitative acylcarnitine profiling in normal humans and in several patients with metabolic errors. Anal Biochem 176: 85-95
34. Mitchell ME (1978) Carnitine metabolism in human subjects. I. Normal metabolism. Am J Clin Nutr 31: 293-306
35. Mitchell ME (1978) Carnitine metabolism in human subjects. II. Values of carnitine in biological fluids and tissues of "normal" subjects. Am J Clin Nutr 31: 481-491
36. Mitchell ME (1978) Carnitine metabolism in human subjects. III. Metabolism in disease. Am J Clin Nutr 31: 645-659
37. Novak M, Monkus EF, Chung D, Buch M (1981) Carnitine in the perinatal metabolism of lipids. I. Relationship between maternal and fetal plasma levels of carnitine and acylcarnitines. Pediatrica 67: 95
38. Novak M, Monkus EF, Buch M, Lesmes H, Silverio J (1983) The effect of a L-carnitine supplement soybean formula on plasma lipids of infants. Acta Chir Scand [Suppl] 517: 149-155
39. Novak M, Penn-Walker D, Hahn P, Monkus EF (1975) Effects of carnitine on lypolysis in subcutaneous adipose tissue of newborns. Biol Neonate 25: 84-94
40. Novak M, Penn-Walker D, Monkus EF (1975) Oxidation of fatty acids by mitochondria obtained from newborn subcutaneous (white) adipose tissue. Biol Neonate 25: 95-107
41. Ohtani Y, Ohyanagi K, Yamamoto S, Matsuda I (1988) Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency. J Pediatr 112: 409-414
42. Olson AL, Rebouche CJ (1987) γ-Butyrobetaine hydroxylase activity is not rate limiting for carnitine biosynthesis in the human infant. J Nutr 117: 1024-1031
43. Rider ED, Jobe AH, Idegami M, Yamada T, Seidner S (1990) Antenatal betamethasone dose effects in preterm rabbits studied at 27 days gestation. J Appl Physiol 68: 1134-1141
44. Rebouche CJ (1992) Carnitine function and requirement during the life cycle. FASEB J 6: 3379-3386
45. Rebouche CJ, Lehman LJ, Olson L (1986) ε-N-Trimethyl-lysine availability regulates the rate of carnitine biosynthesis in the growing rate. J Nutr 116: 751-759
46. Rebouche CJ (1991) Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr 541: 147-152
47. Rebouche CJ (1983) Effect of dietary carnitine isomeres and γ-butyrobetaine on L-carnitine biosynthesis and metabolism in the rat. J Nutr 113: 1906-1913
48. Rebouche CJ, Bosch EP, Chenard CA, Schabold KJ, Nelson SE (1989) Utilization of dietary precursors for carnitine synthesis in human adults. J Nutr 119: 1907-1913
49. Roberts WE, Morrison JC (1991) Pharmacologic induction of fetal lung maturity. Clin Obstet Gynecol 34: 319-327
50. Roe CR, Millington DS, Maltby DA (1986) Identification of 3-methylglutarylcarnitine. J Clin Invest 77: 1391-1394
51. Rooney SA, Young SL, Mendelson CR (1994) Molecular and cellular processing of lung surfactant. FASEB J 8: 957-967
52. Salzer H, Husslein P, Lohninger A, Binstorfer E, Langer M, Schönbauer M, Wagner G, Simbruner G, Popow Ch (1983) Erste Mitteilung: Alternativen zur Cortisontherapie. Erste klinische Erfahrungen mit einer Carnitin-Betamethason-Kombination zur Stimulation der fetalen Lungenreife. Wien Klin Wochenschr 95: 724-728
53. Salzer H, Lohninger A, Sevelda P, Legenstein E (1985) Carnitin zur Stimulierung der fetalen Lungenreife. Gynäkologe 25: 72-85
54. Schek A (1994) Sinn und Unsinn der Substitution einer körpereigenen Substanz. Teil 1: Zur Physiologie und sinn vollen Substitution. Ernährungs-Umschau 41: 9-15
55. Schmidt-Sommerfeld E, Penn D, Wolf H (1983) Carnitine deficiency in premature infants receiving total parenteral nutrition: effect of carnitine supplementation. J Pediatr 102: 931-935
56. Schoderbeck M, Auer B, Legenstein E, Genger H, Sevelda P, Salzer H, März R, Lohninger A (1995) Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med 23 (in press)
57. Scholte HR, Stinis JT (1978) Low carnitine levels in serum of pregnant women. N Engl J Med 299: 1079
58. Sheehan PM, Yeh YY (1984) Pathways of acetyl CoA production of lipogenesis from acetoacetate, β-hydroxybutyrate. pyruvate and glucose in neonatal rat lung. Lipids 19: 103-108
59. Strack E, Dieckhoff J, Theile L, Rotzsch W (1960) Wirkungen von Carnitin auf den physiologischen Gewichtssturz von Fruhgeborenen und auf das Wachstum von Säuglingen. Z Kinderheilkd 84: 458-468
60. Stumpf DA, Parker WD jr, Angelini C (1985) Carnitine deficiency, organic acidemias, and Reye's syndrome. Neurology 35: 1041-1045
61. Stumpf DA, Tyler HR, Dawson DM (1979) Mitochondrial multisystem disorders: clinical, biochemical and morphological features. Current neurology, vol 2. Houghton-Mifflin Publ., New York, pp 117-149
62. Warshaw JB, Curry E (1980) Comparison of serum carnitine and ketone body concentration in breast- and in formula-fed newborn infants. J Pediatr 97: 122-125
63. Winter S, Vance WH, Zorn EM, Vance CK, Jue K, Opala G, Linn L, Szabo A, Winter H, Bakas M (1992) Carnitine deficiency in paediatrics: experience at Valley Children's Hospital, Fresno, California. In: Ferrari R, Dimauro S, Sherwood G (eds) L-Carnitine and its role in medicine: from function to therapy, Academic Press, London, pp 209-221
64. Wright JR, Clements JA (1987) Metabolism and turnover lung surfactant. Am Rev Respir Dis 135: 426-444